> Business > Business Daily
Huahai Company Pilots Globalization of China Pharmaceutics
Text Size:A A A 2018-03-09

Zhejiang Huahai Pharmaceutical Co., Ltd. decided to upgrade medicine feedstocks industry into pharmaceutical engineering 14 years ago. Since then, it has executed international development strategy, aiming at being the pilot of China’s pharmaceutical transformation.

Years of struggle enables Huahai to achieve a total assets of 8.2 billion yuan, being the first large-scaled Chinese pharmaceutics exporter in the United States. 

At present, Huahai’s sales network has basically covered all the large and medium-sized pharmaceutical purchasers in the United States and its brand has been recognized by US Mainstream industries. For example, its antihypertensive product, potassium chloride, has entered sales list of American top pharmaceutics chain Walgreen. The company has also offered preparation products, Ropiniro, donepezil and urbersartan independently to America’s third largest drug retail chain Rite Aid.

【Print】 【Close】
Produced By 大汉网络 大汉版通发布系统